Four leaders from U.S.-based healthcare organizations were featured in Fortune's "100 Most Powerful People in Business" list, released Nov. 12. Fortune editors scored candidates based on metrics ...

Hanne Eliassen Jørgensen har boet i sit elskede hjem i Følle i Østjylland i 20 år. Men sidste år startede et vådt mareridt, ...

»Betyder det så, at de rige skal have lov til at købe lige så mange bøffer og flyrejser, som de vil, og de fattige kan blive ...

Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

The new Storstrøm Bridge, connecting Falster and Masnedø in Denmark, is nearing completion after over two years of construction, TV2 reports. Only the final two bridge girders need to be installed to ...

After the 2024 U.S. election, Vermont Senator Bernie Sanders delivered a sharp critique of the Democratic party, asserting ...

A day after the warning landed on semaglutide labels, Novo Nordisk CEO Lars Fruergaard Jørgensen said he is alarmed by the amount of unsafe compounded GLP-1s in the U.S. market, adding that the ...

Regeringens nye life science-strategi vil styrke den danske nøglesektors konkurrenceevne. Den bør inspirere et udfordret ...

Denmark’s Prime Minister Mette Frederiksen and President-elect Donald Trump are both regarded as straight-talking politicians.When Trump, as American president, expressed an interest in buying ...

Lars Fruergaard Jørgensen, Novo Nordisk CEO, joins 'Money Movers' to discuss Jorgensen's comments on demand in 2025, if demand is waning for GLP-1 drugs, and much more.

Novo Nordisk’s CEO has alerted healthcare professionals about the growing risks associated with compounded semaglutide, a ...